The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...
WASHINGTON, D.C.– The U.S. National Security Commission on Emerging Biotechnology issued its first report since its creation through the National Defense Authorization Act of FY2022. The bipartisan ...
Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...
A research team led by Professor Wang Peng from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, ...
The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...
America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.
The biotechnology market is anticipated to expand at a rapid pace owing to high incidence of chronic diseases, growing demand for novel treatments, and advancements in cell technologies. Surge in ...
DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback